01 July 1999
Clostridium difficile as aetiological factor of diarrhoea in hospitalised patients on antibiotic therapy
Eugenia Gospodarek, Agnieszka Mikucka, Ewa SieradzkaMed Sci Monit 1999; 5(4): BR647-651 :: ID: 503465
Abstract
The infection with Clostridium difficile is one of the most important causes of diarrhoea in patients after antibiotic therapy. Toxins produced by these bacteria damage enterocytes which leads to acute colitis, while the infection requires specific treatment. Microbiological analysis of the presence of C. difficile was performed on 62 faecal samples obtained from patients with the diagnosis of PMC, AAD. The culture was established on the basis of the faeces as well as faecal samples treated with ethyl alcohol. The media with cultures were incubated at 37¡C in anaerobic conditions, using Generbox system (bio-Merieux). Simultaneously, a culture in aerobic conditions was conducted. All faecal samples and isolated C. difficile strains were investigated with respect to toxigenicity with the use of CULTURETTE BRAND Toxin CD Test (Becton Dickinson) or C. difficile Toxin A Test (Oxoid). On the whole, 23 (37.10%) C. difficile strains were cultured, out of which 11 (47.83%) produced toxin A. The majority of analysed material was obtained from patients with clinical diagnosis of AAD (83.87%). In this group 19, (36.54%) C. difficile strains were isolated; 9 (47.37%) of them were toxigenic. Toxin A test performed directly in the faeces revealed the presence of toxin A in 3 (4.84%) samples obtained from patients with AAD. Among faecal samples with negative result of a test for the presence of C. difficile, multiresistant strains of Gram-negative bacilli were isolated in 6 cases, including the strains resistant to the antibiotics used in the treatment of these patients. Enterococcus spp. resistant to antibiotics were isolated from 5 faecal samples. Two Enterococcus sp. strains resistant to antibiotics were isolated from the samples of the faeces, in which C. difficile was cultured. All the Enterococcus sp. strains were sensitive to glycopeptides. The use of ethyl alcohol in the treatment of faecal samples in C. difficile diagnostics enables to obtain this bacteria in a monoculture which speeds up the result of the investigation by 1Ð2 days. It is advisable to include tests for the presence of C. difficile in the diagnostics of diarrhoea related to previously used antibiotic therapy, and to pay special attention to the presence and antibiotic-sensitivity of other micro-organisms.
Keywords: C. difficile, pseudomembranous colitis, antibiotic associated diarrhoea
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952